ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,193,320 | +3.2% | 156,000 | 0.0% | 1.08% | +14.2% |
| Q2 2023 | $3,093,480 | +186.6% | 156,000 | +147.6% | 0.94% | +213.0% |
| Q1 2023 | $1,079,190 | -12.3% | 63,000 | 0.0% | 0.30% | -20.8% |
| Q4 2022 | $1,231,020 | +22.5% | 63,000 | 0.0% | 0.38% | +18.0% |
| Q3 2022 | $1,005,000 | -98.4% | 63,000 | +7158.1% | 0.32% | -51.0% |
| Q2 2022 | $63,000,000 | +252.3% | 868 | -98.6% | 0.66% | -83.7% |
| Q1 2022 | $17,884,000 | +1200.7% | 63,000 | 0.0% | 4.03% | +1218.0% |
| Q4 2021 | $1,375,000 | -27.0% | 63,000 | 0.0% | 0.31% | -32.6% |
| Q3 2021 | $1,883,000 | – | 63,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |